Latest News & Updates of Loncom Pharma

IntroductionIn the realm of pharmaceutical advancements, the development of effective and safe active pharmaceutical ingredients (APIs) is crucial for improving patient outcomes. Among the latest innovations, Linzagolix Choline has emerged as a promising API, particularly in the treatment of endomet

Season's Greetings from Shandong Loncom Pharmaceutical As we reflect on a year full of achievements and collaborations, we want to extend our warmest wishes to all of our valued partners. Your trust and support have been vital in helping us advance our mission to improve women's health worldwide.Mer

At Loncom Pharmaceutical, we believe that health is the cornerstone of a fulfilling life, and we understand that women's health needs are unique. Throughout our years of research and development, we have remained dedicated to creating innovative pharmaceutical solutions that cater specifically to wo

Abemaciclib, developed by Eli Lilly, represents a significant advancement in the treatment of advanced or metastatic breast cancer. Its approval in September 2017 by the US FDA marked a new chapter for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HE